Skip to Content

Exametazime Pregnancy and Breastfeeding Warnings

Exametazime is also known as: Ceretec, Drax Exametazime

Exametazime Pregnancy Warnings

FDA pregnancy category: C Potential benefit should outweigh the potential risk.

Animal reproduction studies have not been conducted. It is not known whether Tc99m exametazime can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Exametazime Breastfeeding Warnings

The manufacturer recommends formula feedings for 60 hours following administration.

Breast-feeding is not recommended during use of exametazime. Excreted into human milk: Yes (technetium Tc99m); unknown (exametazime) Excreted into animal milk: Unknown The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Ceretec (exametazime)." GE Healthcare, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Ceretec (exametazime)." GE Healthcare, Princeton, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.